Personal information

Activities

Works (3)

Early Initiation of Adalimumab Significantly Diminishes Postoperative Crohn’s Disease Endoscopic Recurrence and Is Superior to 6-Mercaptopurine Therapy: An Open-Label, Randomized Controlled Study

Journal of Clinical Medicine
2023-12-10 | Journal article
Contributors: Ayal Hirsch; Erez Scapa; Naomi Fliss-Isakov; Hagit Tulchinsky; Eran Itzkowitz; Yehuda Kariv; Yulia Ron; Henit Yanai; Ian White; Sharief Yassin et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Early Initiation of Adalimumab Significantly Diminishes Post-operative Crohn’s Disease Endoscopic Recurrence and Is Superior to 6-Mercaptopurine Therapy. An Open Label Randomized Controlled Study

2023-10-25 | Preprint
Contributors: Ayal Hirsch; Erez Scapa; Naomi Fliss Isakov; Hagit Tulchinsky; Eran Itzkowitz; Yehuda Kariv; Yulia Ron; Henit Yanai; Ian White; Sharif Yassin et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Crohn’s Disease Exclusion Diet for the Treatment of Crohn’s Disease: Real-World Experience from a Tertiary Center

Journal of Clinical Medicine
2023-08-21 | Journal article
Contributors: Naomi Fliss-Isakov; Nathaniel Aviv Cohen; Ahuva Bromberg; Gal Elbert; Ronit Anbar; Yulia Ron; Ayal Hirsch; Tamar Thurm; Nitsan Maharshak
Source: check_circle
Crossref
grade
Preferred source (of 2)‎